Form C/A — AlphaRose Therapeutics Inc
0001665160-25-001394 · filed Aug 27, 2025
· via StartEngine Primary, LLC
Offering
- Target
- $19,998
- Maximum
- $4,999,999
- Security type
- Common Stock
- Price per security
- $1.3500
- Deadline
- —
- Oversubscription
- Accepted
Issuer
- CIK
- 2051498
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 1401 LAVACA STREET, #851
AUSTIN, TX 78701 - Phone
- —
Most recent fiscal year financials
- Total assets
- $614,498
- Cash
- —
- Short-term debt
- $81,098
- Long-term debt
- $1,151,098
- Revenues
- —
- COGS
- —
- Taxes paid
- —
- Net income
- $-625,253
View the original filing on SEC EDGAR ↗